Barclays Reiterates an 'Overweight' on Corporate Executive Board (EXBD); Q2 Beat...Expect Acceleration Into 2013

July 31, 2012 3:38 PM EDT
Get Alerts EXBD Hot Sheet
Price: $46.25 +1.07%

Rating Summary:
    0 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays reiterates an 'Overweight' on Corporate Executive Board (NYSE: EXBD) price target of $54.00.

Analyst, Gary E. Bisbee, commented on the company's strong Q2 earnings release, saying metrics have re-accelerated on a sequential basis, therefore indicating solid momentum.

Bisbee said, "In our view, EXBD has a strong business model with high margins/returns and cash flows equal to ~150% of net income...we expect strong growth in 2012 and 2013. We find the stock attractively valued at a sharp discount to subscription model peers."

FY12 EPS estimate raised from $1.90 to $2.00 and FY13 from $2.10 to $2.18.

For an analyst ratings summary and ratings history on Corporate Executive Board click here. For more ratings news on Corporate Executive Board click here.

Shares of Corporate Executive Board closed at $42.09 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View

Related Entities

Barclays, Earnings